Literature DB >> 2302330

Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension.

K P O'Hagan1, G D Thomas, E J Zambraski.   

Abstract

The role of renal sympathetic nerve activity (RSNA) in the maintenance phase of essential hypertension has not yet been clearly defined. Renal function and mean arterial pressure (MAP) were studied in four Yucatan miniature swine (YMS) with established DOCA hypertension prior to and for 3 weeks after surgical renal denervation (RDX). During the first week post-RDX, MAP decreased from 141 /+- 6 to 121 +/- 3 mm Hg (P less than .05), while sodium balance increased from 0.32 +/- 0.05 to 0.95 +/- 0.14 mEq/kg/day (P less than .05). By 3 weeks post-RDX, MAP remained below normotensive levels while sodium balance returned to the pre-RDX value. There was no significant change in potassium or water balance after RDX. Thus, in DOCA-YMS the renal nerves are important in the maintenance of hypertension. The reduction in MAP with RDX in the absence of a natriuresis suggests a role for renal afferent nerve activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302330     DOI: 10.1093/ajh/3.1.62

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  11 in total

Review 1.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

2.  Renal sympathetic denervation in resistant hypertension.

Authors:  Mário Santos; Henrique Carvalho
Journal:  World J Cardiol       Date:  2013-04-26

3.  Early life stress sensitizes the renal and systemic sympathetic system in rats.

Authors:  Analia S Loria; Michael W Brands; David M Pollock; Jennifer S Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-15

4.  CrossTalk opposing view: Which technique for controlling resistant hypertension? Renal nerve ablation.

Authors:  Markus P Schlaich; Yusuke Sata; Murray D Esler
Journal:  J Physiol       Date:  2014-09-15       Impact factor: 5.182

Review 5.  Renal denervation in the treatment of hypertension.

Authors:  Christian Ukena; Felix Mahfoud; Sebastian Ewen; Bodo Cremers; Ulrich Laufs; Michael Böhm
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 6.  Renal Denervation Therapy for Drug-Resistant Hypertension: Does It Still Work?

Authors:  Venkatesh K Raman; Costas Tsioufis; Michael Doumas; Vasilios Papademetriou
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

7.  Role of cardiac sympathetic nerves in blood pressure regulation.

Authors:  Erica A Wehrwein; Misa Yoshimoto; Pilar Guzman; Amit Shah; David L Kreulen; John W Osborn
Journal:  Auton Neurosci       Date:  2014-03-01       Impact factor: 3.145

Review 8.  Renal denervation and treatment of hypertension.

Authors:  Ralph Knöll
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

9.  Sympatho-renal axis in chronic disease.

Authors:  Paul A Sobotka; Felix Mahfoud; Markus P Schlaich; Uta C Hoppe; Michael Böhm; Henry Krum
Journal:  Clin Res Cardiol       Date:  2011-06-19       Impact factor: 5.460

Review 10.  Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade.

Authors:  Marco Antônio Peliky Fontes; Lucas Alexandre Santos Marzano; Carina Cunha Silva; Ana Cristina Simões E Silva
Journal:  J Bras Nefrol       Date:  2020-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.